Site Editor

Joyce F. Liu, MD, MPH

Advertisement
Advertisement

Daniela E. Matei, MD on Biology-Driven Therapy for Ovarian Cancer

Posted: Thursday, February 6, 2025

Daniela E. Matei, MD, of Northwestern Medicine, Feinberg School of Medicine, discusses the currently known targets of biology-driven therapy for ovarian cancer and several of the ongoing trials of newer agents that may ultimately impact the clinical care of patients with this type of gynecologic cancer in the future.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.